It’s been a couple of months since Utah raised eyebrows by allowing the startup Doctronic to use AI to refill prescriptions. Turns out, the state

Adding Merck’s Welireg to an existing Keytruda regimen didn’t lead to a significant improvement in newly diagnosed patients with advanced kidney cancer, Merck announced on

UnitedHealth Group said Tuesday it’s on track to invest $1.5 billion in artificial intelligence this year, both to improve its own operations and provide products

SAN DIEGO — Since Herceptin’s approval in 1998, breast cancer has been reshaped from a near-term death sentence into — in many cases — a

Carvykti shows promise in patients before full-blown multiple myeloma: Researchers from Dana-Farber Cancer Institute shared that 20 patients with high-risk smoldering multiple myeloma all saw